Pitt team redesigns epilepsy drug to increase potency and specificity, reduce side effects
(University of Pittsburgh Schools of the Health Sciences) A Pitt team has designed a more effective version of an FDA-approved epilepsy drug with the potential for fewer side effects, according to a study published recently in Molecular Pharmacology. The experimental agent could also prove to be a treatment for tinnitus and other disorders caused by volatile neural signaling.
Source: EurekAlert! - Biology - Category: Biology Source Type: news
More News: Biology | Drugs & Pharmacology | Epilepsy | Health | Molecular Biology | Schools | Study | Tinnitus